Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gene-based Advanced Therapy Medical Product market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gene-based Advanced Therapy Medical Productmarket, defines the market attractiveness level of Gene-based Advanced Therapy Medical Product market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gene-based Advanced Therapy Medical Product industry, describes the types of Gene-based Advanced Therapy Medical Product market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gene-based Advanced Therapy Medical Product market and the development prospects and opportunities of Gene-based Advanced Therapy Medical Product industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gene-based Advanced Therapy Medical Product market in Chapter 13.
By Player:
Amgen
SIBIONO
Gilead Sciences
AnGes
Sunway Biotech
bluebird bio
Sarepta Therapeutics
Orchard Therapeutics
Biogen
Novartis
Akcea Therapeutics
Human Stem Cells Institute
Alnylam Pharmaceuticals
Spark Therapeutics
By Type:
Viral Gene Delivery System
Non-viral Gene Delivery System
By End-User:
Neurological Diseases
Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gene-based Advanced Therapy Medical Product Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gene-based Advanced Therapy Medical Product Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gene-based Advanced Therapy Medical Product Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gene-based Advanced Therapy Medical Product Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gene-based Advanced Therapy Medical Product Market Analysis and Outlook to 2022
-
7.1 Global Gene-based Advanced Therapy Medical Product Consumption (2017-2022)
-
7.2 United States Gene-based Advanced Therapy Medical Product Consumption (2017-2022)
-
7.3 Europe Gene-based Advanced Therapy Medical Product Consumption (2017-2022)
-
7.4 China Gene-based Advanced Therapy Medical Product Consumption (2017-2022)
-
7.5 Japan Gene-based Advanced Therapy Medical Product Consumption (2017-2022)
-
7.6 India Gene-based Advanced Therapy Medical Product Consumption (2017-2022)
-
7.7 South Korea Gene-based Advanced Therapy Medical Product Consumption (2017-2022)
8 Region and Country-wise Gene-based Advanced Therapy Medical Product Market Analysis and Outlook to 2028
-
8.1 Global Gene-based Advanced Therapy Medical Product Consumption Forecast (2022-2028)
-
8.2 United States Gene-based Advanced Therapy Medical Product Consumption Forecast (2022-2028)
-
8.3 Europe Gene-based Advanced Therapy Medical Product Consumption Forecast (2022-2028)
-
8.4 China Gene-based Advanced Therapy Medical Product Consumption Forecast (2022-2028)
-
8.5 Japan Gene-based Advanced Therapy Medical Product Consumption Forecast (2022-2028)
-
8.6 India Gene-based Advanced Therapy Medical Product Consumption Forecast (2022-2028)
-
8.7 South Korea Gene-based Advanced Therapy Medical Product Consumption Forecast (2022-2028)
9 Global Gene-based Advanced Therapy Medical Product Market Outlook by Types and Applications to 2022
-
9.1 Global Gene-based Advanced Therapy Medical Product Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Viral Gene Delivery System Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-viral Gene Delivery System Consumption and Growth Rate (2017-2022)
-
9.2 Global Gene-based Advanced Therapy Medical Product Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Neurological Diseases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Gene-based Advanced Therapy Medical Product Market Outlook by Types and Applications to 2028
-
10.1 Global Gene-based Advanced Therapy Medical Product Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Viral Gene Delivery System Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non-viral Gene Delivery System Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gene-based Advanced Therapy Medical Product Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Neurological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Gene-based Advanced Therapy Medical Product Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gene-based Advanced Therapy Medical Product Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gene-based Advanced Therapy Medical Product Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gene-based Advanced Therapy Medical Product Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gene-based Advanced Therapy Medical Product Market Competitive Analysis
-
14.1 Amgen
-
14.1.1 Amgen Company Details
-
14.1.2 Amgen Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen Gene-based Advanced Therapy Medical Product Product and Service
-
14.2 SIBIONO
-
14.2.1 SIBIONO Company Details
-
14.2.2 SIBIONO Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 SIBIONO Gene-based Advanced Therapy Medical Product Product and Service
-
14.3 Gilead Sciences
-
14.3.1 Gilead Sciences Company Details
-
14.3.2 Gilead Sciences Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Gilead Sciences Gene-based Advanced Therapy Medical Product Product and Service
-
14.4 AnGes
-
14.4.1 AnGes Company Details
-
14.4.2 AnGes Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AnGes Gene-based Advanced Therapy Medical Product Product and Service
-
14.5 Sunway Biotech
-
14.5.1 Sunway Biotech Company Details
-
14.5.2 Sunway Biotech Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sunway Biotech Gene-based Advanced Therapy Medical Product Product and Service
-
14.6 bluebird bio
-
14.6.1 bluebird bio Company Details
-
14.6.2 bluebird bio Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 bluebird bio Gene-based Advanced Therapy Medical Product Product and Service
-
14.7 Sarepta Therapeutics
-
14.7.1 Sarepta Therapeutics Company Details
-
14.7.2 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Product and Service
-
14.8 Orchard Therapeutics
-
14.8.1 Orchard Therapeutics Company Details
-
14.8.2 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Product and Service
-
14.9 Biogen
-
14.9.1 Biogen Company Details
-
14.9.2 Biogen Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Biogen Gene-based Advanced Therapy Medical Product Product and Service
-
14.10 Novartis
-
14.10.1 Novartis Company Details
-
14.10.2 Novartis Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis Gene-based Advanced Therapy Medical Product Product and Service
-
14.11 Akcea Therapeutics
-
14.11.1 Akcea Therapeutics Company Details
-
14.11.2 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Product and Service
-
14.12 Human Stem Cells Institute
-
14.12.1 Human Stem Cells Institute Company Details
-
14.12.2 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Product and Service
-
14.13 Alnylam Pharmaceuticals
-
14.13.1 Alnylam Pharmaceuticals Company Details
-
14.13.2 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Product and Service
-
14.14 Spark Therapeutics
-
14.14.1 Spark Therapeutics Company Details
-
14.14.2 Spark Therapeutics Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Spark Therapeutics Gene-based Advanced Therapy Medical Product Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gene-based Advanced Therapy Medical Product
-
Figure Gene-based Advanced Therapy Medical Product Picture
-
Table Global Gene-based Advanced Therapy Medical Product Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene-based Advanced Therapy Medical Product Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene-based Advanced Therapy Medical Product Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gene-based Advanced Therapy Medical Product Consumption by Country (2017-2022)
-
Figure United States Gene-based Advanced Therapy Medical Product Consumption and Growth Rate (2017-2022)
-
Table Europe Gene-based Advanced Therapy Medical Product Consumption and Growth Rate (2017-2022)
-
Figure China Gene-based Advanced Therapy Medical Product Consumption and Growth Rate (2017-2022)
-
Figure Japan Gene-based Advanced Therapy Medical Product Consumption and Growth Rate (2017-2022)
-
Figure India Gene-based Advanced Therapy Medical Product Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gene-based Advanced Therapy Medical Product Consumption and Growth Rate (2017-2022)
-
Figure Global Gene-based Advanced Therapy Medical Product Consumption Forecast by Country (2022-2028)
-
Figure United States Gene-based Advanced Therapy Medical Product Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gene-based Advanced Therapy Medical Product Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gene-based Advanced Therapy Medical Product Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gene-based Advanced Therapy Medical Product Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gene-based Advanced Therapy Medical Product Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gene-based Advanced Therapy Medical Product Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Viral Gene Delivery System Consumption and Growth Rate (2017-2022)
-
Figure Global Non-viral Gene Delivery System Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Viral Gene Delivery System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-viral Gene Delivery System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gene-based Advanced Therapy Medical Product Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gene-based Advanced Therapy Medical Product Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Gene-based Advanced Therapy Medical Product Product and Service
-
Table SIBIONO (Foundation Year, Company Profile and etc.)
-
Table SIBIONO Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table SIBIONO Gene-based Advanced Therapy Medical Product Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Gene-based Advanced Therapy Medical Product Product and Service
-
Table AnGes (Foundation Year, Company Profile and etc.)
-
Table AnGes Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table AnGes Gene-based Advanced Therapy Medical Product Product and Service
-
Table Sunway Biotech (Foundation Year, Company Profile and etc.)
-
Table Sunway Biotech Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunway Biotech Gene-based Advanced Therapy Medical Product Product and Service
-
Table bluebird bio (Foundation Year, Company Profile and etc.)
-
Table bluebird bio Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table bluebird bio Gene-based Advanced Therapy Medical Product Product and Service
-
Table Sarepta Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Product and Service
-
Table Orchard Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Orchard Therapeutics Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orchard Therapeutics Gene-based Advanced Therapy Medical Product Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Gene-based Advanced Therapy Medical Product Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Gene-based Advanced Therapy Medical Product Product and Service
-
Table Akcea Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Akcea Therapeutics Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akcea Therapeutics Gene-based Advanced Therapy Medical Product Product and Service
-
Table Human Stem Cells Institute (Foundation Year, Company Profile and etc.)
-
Table Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Product and Service
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Product and Service
-
Table Spark Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Spark Therapeutics Gene-based Advanced Therapy Medical Product Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spark Therapeutics Gene-based Advanced Therapy Medical Product Product and Service
-
